TITLE

Worsening of steatosis and fibrosis progression in hepatitis C

AUTHOR(S)
Cast''ra L; Pawlotsky J-M; Dhumeaux D
PUB. DATE
October 2003
SOURCE
Gut;Oct2003, Vol. 52 Issue 10, p1531
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
10854363

 

Related Articles

  • Worsening of steatosis is an independent factor of fibrosis progression in untreated patients with chronic hepatitis C and paired liver biopsies. Castéra, L.; Hézode, C.; Roudot-Thoraval, F.; Bastie, A.; Zafrani, E.-S.; Pawlotsky, J.-M.; Dhumeaux, D. // Gut;Feb2003, Vol. 52 Issue 2, p288 

    Background and aims: Steatosis, a frequent histological finding in patients with chronic hepatitis C (CHC), has been suggested to influence liver fibrosis progression. The aim of the present study was to evaluate in patients with CHC and paired liver biopsies the relationship between the...

  • Association of steatosis with histopathological grading and staging of liver biopsies in hepatitis C patients. Syed, Shuja Izhar; Sadiq, Saleem // Pakistan Journal of Medical Sciences;Apr2011, Vol. 27 Issue 3, p638 

    Objective: To find out the association of steatosis with histopathological grading and staging of liver biopsies in hepatitis C patients. Methodology: This was a prospective study based on liver biopsies of hepatitis C patients. H and E stained slides were examined to determine the histological...

  • HOST AND VIRAL CHARACTERISTICS ASSOCIATED WITH STEATOSIS IN CHRONIC HEPATITIS C.  // Gut;Apr2004 Supplement 3, Vol. 53, pA82 

    Steatosis is a frequent histological finding in chronic hepatitis C virus (HCV); however, the pathophysiology of steatosis and its role in disease progression is controversial. It has been suggested that steatosis is associated with genotype 3 and that steatosis could accelerate progression of...

  • HEPATOLOGY.  // Current Medical Literature: Gastroenterology;2005, Vol. 24 Issue 4, p75 

    The section presents the results of several studies related to hepatology. The topics include the prevalence of and risk factors for non-alcoholic fatty liver disease, the link between daily cannabis smoking and the progression of fibrosis in chronic hepatitis C, insulin resistance and steatosis...

  • STEATOSIS IN CHRONIC HEPATITIS C: WHY DOES IT REALLY MATTER? Asselah, T.; Rubbia-Brandt, L.; Marcellin, P.; Negro, F. // Gut;Jan2006, Vol. 55 Issue 1, p123 

    Hepatic steatosis is a common histological feature of chronic hepatitis C. Various factors are associated with hepatic steatosis, including obesity, high alcohol consumption, diabetes type II, and hyperlipidaemia. These factors may contribute to steatosis in patients with chronic hepatitis C. In...

  • Hepatic steatosis: A benign disease or a silent killer. El-Zayadi, Abdel-Rahman // World Journal of Gastroenterology;7/14/2008, Vol. 14 Issue 26, p4120 

    Steatosis is a common feature of many liver diseases, namely non-alcoholic steatohepatitis (NASH) and hepatitis C virus (HCV) infection, but the pathogenic mechanisms differ. Insulin resistance (IR), a key feature of metabolic syndrome, is crucial for NASH development, associated with many...

  • Steatosis and hepatic expression of genes regulating lipid metabolism in Japanese patients infected with hepatitis C virus. Yasui, Kohichiroh; Harano, Yuichi; Mitsuyoshi, Hironori; Tsuji, Kazuhiro; Endo, Mio; Nakajima, Tomoaki; Minami, Masahito; Itoh, Yoshito; Yoh Zen; Nakanuma, Yasuni; Yoshikawa, Toshikazu; Okanoue, Takeshi // Journal of Gastroenterology;Jan2010, Vol. 45 Issue 1, p95 

    Steatosis is a histological finding associated with the progression of chronic hepatitis C. The aims of this study were to elucidate risk factors associated with steatosis and to evaluate the association between steatosis and hepatic expression of genes regulating lipid metabolism. We analyzed...

  • Hepatitis C Virus-Induced Hepatocellular Steatosis. Castera, Laurent; Chouteau, Philippe; Hezode, Christophe; Zafrani, Elie-Serge; Dhumeaux, Daniel; Pawlotsky, Jean-Michel // American Journal of Gastroenterology;Mar2005, Vol. 100 Issue 3, p711 

    Two distinct forms of hepatocellular steatosis can be seen in patients with chronic hepatitis C virus (HCV) infection. Classical metabolic risk factors for hepatocellular steatosis account for the vast majority of cases of steatosis in patients infected by non-genotype 3 HCV strains. In...

  • Quantification of portal-bridging fibrosis area more accurately reflects fibrosis stage and liver stiffness than whole fibrosis or perisinusoidal fibrosis areas in chronic hepatitis C. Sandrini, Jérémy; Boursier, Jérôme; Chaigneau, Julien; Sturm, Nathalie; Zarski, Jean-Pierre; Le Bail, Brigitte; de Ledinghen, Victor; Calès, Paul; Rousselet, Marie-Christine // Modern Pathology;Jul2014, Vol. 27 Issue 7, p1035 

    No abstract available.

  • COMPONENTA METABOLICf A INFECÅ¢IEI VIRALE C. Crişan, Dana // Clujul Medical;Mar2010, Vol. 83 Issue 1, p31 

    Chronic hepatitis C is a major health problem in Romania. Infection with hepatitis C virus is not restricted to liver, but it implies multiple metabolic connotations. There are numerous evidences that support this statement: insulin resistance, raised fasting plasma glucose, hepatic steatosis,...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics